Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorHagaZiekenhuis

About this trial

This multi-center pilot study compares conventional DBS (cDBS) and adaptive DBS (aDBS) in Parkinson's disease patients using the Medtronic Percept™ system.

The aim of the study is to identify which patients benefit most from aDBS, and to explore patient and LFP signal characteristics as well as stimulation parameters as potential predictors of treatment preference and efficacy. The study utilizes a blinded, randomized N-of-1 trial design, where each patient tests the following:

* Original cDBS settings (cDBS); * Optimized cDBS settings (O-cDBS); * Optimized aDBS settings (O-aDBS) Each setting is evaluated for a minimum of 2 and maximum of 7 days at home in a randomized order (patient blinded).

The main study outcome consists of the patient's final preference among the three DBS programs: original cDBS, O-cDBS, or O-aDBS. Secondary outcomes focus on differences between cDBS, O-cDBS and O-aDBS regarding the following parameters (among others):

* Quality of life (PDQ-39); * Patient satisfaction (5-point Likert Scale); * (Non)-motor fluctuations (MDS-UPDRS-III + MDS-NMS-Q); * Time spent in "ON"/"OFF" motor phases (symptom diary + MDS-UPDRS IV); * Time spent experiencing dyskinesia (symptom diary + MDS-UPDRS IV); * Time spent with the most bothersome symptom (symptom diary + MDSUPDRS IV); * Stimulation parameters; * Local field potentials.

The study also incorporates real-world home-based assessments using the Experience Sampling Method (ESM) to capture motor and non-motor symptom fluctuations in daily life and identify differences among the three settings.

Eligibility criteria

Qualifiers

Patients with Parkinson's disease with bilateral DBS in the STN

DBS surgery with implantation of the Percept™ PC/RC system performed at least 6 months ago

Symptoms such as dysarthria, freezing, or ON-OFF fluctuations that are insufficiently controlled

A usable LFP signal is present on at least one side

Disqualifiers

Patients for whom switching to aDBS, operating the remote control independently, or making regular visits to the DBS center is deemed clinically unsafe or unreliable by the treating physician - for example, due to active or unstable cognitive or psychiatric conditions.

High impedance, defective DBS electrodes, or insufficient LFP signal quality, or bilateral stimulation primarily on the most ventral or dorsal contact points, preventing proper functioning of aDBS.

Patients who have objected to the use of their electronic health record data for medical scientific research.

Trial design

Treatments tested in this trial

  • Conventional DBS
  • Optimized conventional DBS
  • Optimized adaptive DBS

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

HagaZiekenhuis

Lead sponsor

Maastricht University Medical Center

Collaborator

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

Collaborator